Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Margaret M. Seminack"'
Autor:
Mary Ann Goss, Fabio Lievano, Adrian Dana, Margaret M. Seminack, Karyn M. Buchanan, Michael L. Cunningham
Publikováno v:
Vaccine. 33:3422-3428
Objective To better describe the safety profile of pregnancy exposures to the qHPV vaccine by acquiring and analyzing post-marketing data on pregnancy outcomes. Methods This is a voluntary, post-marketing prenatal vaccine exposure registry. Enrollmen
Autor:
Susan A. Galea, Trung Nam Tran, Richard T. Wiedmann, Stanley A. Plotkin, Adrian Dana, Margaret M. Seminack, Manisha A. Amin, Fabio Lievano, Susan B. Manoff, Kristen A. Vagie, Michele Thornton
Publikováno v:
Vaccine. 30:6918-6926
M-M-R™II (measles, mumps, and rubella virus vaccine live; Merck, Sharp, & Dohme Corp.) is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals ≥ 12 months of age. Before the vaccine era, these viruses infected
Autor:
Richard M. Haupt, Margaret M. Seminack, Karyn M. Buchanan, Kristine E. Shields, Scott Korn, Michael L. Cunningham, Adrian Dana, Mary Ann Goss
Publikováno v:
Obstetrics & Gynecology. 114:1170-1178
To better describe the safety profile of pregnancy exposures to the human papillomavirus (HPV) type 6/11/16/18 vaccine by acquiring and analyzing postmarketing data on pregnancy outcomes (ie, live births, abortions, fetal deaths, and congenital anoma
Publikováno v:
Obstetrics & Gynecology. 123:93S
INTRODUCTION:Human papillomavirus (HPV) 6/11/16/18 vaccine (qHPV vaccine) is a quadrivalent vaccine for the prevention of cervical, vulvar, and vaginal cancers; their respective precancers; and genital warts caused by these vaccine types. As of Decem